Pang Hua-Yang, Zhao Lin-Yong, Wang Hui, Chen Xiao-Long, Liu Kai, Zhang Wei-Han, Yang Kun, Chen Xin-Zu, Hu Jian-Kun
Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.
Front Oncol. 2021 Oct 11;11:587309. doi: 10.3389/fonc.2021.587309. eCollection 2021.
This study aimed to evaluate the impact of postoperative complication and its etiology on long-term survival for gastric cancer (GC) patients with curative resection.
From January 2009 to December 2014, a total of 1,667 GC patients who had undergone curative gastrectomy were analyzed. Patients with severe complications (SCs) (Clavien-Dindo grade III or higher complications or those causing a hospital stay of 15 days or longer) were separated into a "complication group." Univariate and multivariate analyses were performed to reveal the relationship between postoperative complications and long-term survival. A 2:1 propensity score matching (PSM) was used to balance baseline parameters between the two groups.
SCs were diagnosed in 168 (10.08%) patients, including different etiology: infectious complications (ICs) in 111 (6.66%) and non-infectious complications (NICs) in 71 (4.26%) patients. Multivariate analysis showed that presence of SCs (P=0.001) was an independent prognostic factor for overall survival, and further analysis by complication type demonstrated that the deteriorated overall survival was mainly caused by ICs (P=0.004) rather than NICs (P=0.068). After PSM, patients with SCs (p=0.002) still had a significantly decreased overall survival, and the presence of ICs (P=0.002) rather than NICs (P=0.067) showed a negative impact on long-term survival.
Serious complications, particularly of an infectious type, may have a negative impact on overall survival of GC patients. However, additional multicenter prospective studies with larger sample size are required to verify this issue.
本研究旨在评估术后并发症及其病因对接受根治性切除的胃癌(GC)患者长期生存的影响。
分析2009年1月至2014年12月期间共1667例行根治性胃切除术的GC患者。将发生严重并发症(SCs)(Clavien-Dindo分级为III级或更高级别并发症或导致住院15天或更长时间的并发症)的患者分为“并发症组”。进行单因素和多因素分析以揭示术后并发症与长期生存之间的关系。采用2:1倾向评分匹配(PSM)来平衡两组之间的基线参数。
168例(10.08%)患者被诊断为SCs,包括不同病因:111例(6.66%)为感染性并发症(ICs),71例(4.26%)为非感染性并发症(NICs)。多因素分析显示,SCs的存在(P=0.001)是总生存的独立预后因素,按并发症类型进一步分析表明,总生存恶化主要由ICs(P=0.004)而非NICs(P=0.068)引起。PSM后,发生SCs的患者(p=0.002)总生存仍显著降低,ICs(P=0.002)而非NICs(P=0.067)的存在对长期生存有负面影响。
严重并发症,尤其是感染性并发症,可能对GC患者的总生存有负面影响。然而,需要更多样本量更大的多中心前瞻性研究来验证这一问题。